news aktuell GmbH

Commemorative event to mark the European Holocaust Remembrance Day for Sinti and Roma on 2 August 2026 in Auschwitz-Birkenau

Cologne – CHRIST Juweliere und Uhrmacher, one of Europe's most renowned jewelry retailers, is partnering with fulfillmenttools to transform the way it manages and orchestrates orders across its retail network. CHRIST is implementing the Agentic Order Management System (OMS) – as part of a broader transformation in which the retailer is building a modular, future-proof commerce architecture powered by commercetools Sphere, the autonomous commerce platform. The new system landscape spans stores and digital channels across Germany, Austria and the Netherlands.

Uslar – The Bikeleasing Group announces strategic investment in Workride, New Zealand’s market leader for company bike leasing as an employee benefit. Around 2,000 New Zealand employers already use Workride’s offering. The investment extends the Bikeleasing Group’s international presence and marks its next cross-continental step in its growth trajectory.

Heidelberg/Germany, July 27, 2026—It is with deep sadness that the family and the Institute for Plastination announce the passing of Dr. Gunther von Hagens, inventor of Plastination and creator of the BODY WORLDS exhibitions. He died on July 24, 2026, at the age of 81.

Mainz - A new form for media leaders Leading Today – Shaping Tomorrow As media organizations navigate fundamental shifts in streaming, distribution, artificial intelligence and platform ecosystems, ZDF and SRF are bringing together senior industry leaders for Streamium Days 2026 (September 7–8, 2026), a new international forum dedicated to the future of audience engagement and media distribution.

TOSYALI continues to accelerate its energy transition by securing long term international financing for supporting its decarbonization agenda and sustainability investments. The company has signed Export Finance Buyer Credit Agreements worth 187 million euros with BBVA, under Spanish Export Credit Agency Cesce’s cover, for Osmaniye and Niğde Projects in its first phase of solar power plant (SPP) investments with total capacity of 1.2 GW.

Seventh Sustainability Report highlights expansion of energy and resource sovereignty External ESG rating confirms effective alignment of sustainability with strategic risk management Climate transition plan serves as central instrument for future-proofing business processes

Warsaw, 21.07.2026 - Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe. With Biofarm joining the Group, Polpharma is expanding the scale of its operations, reinforcing its presence in key regional markets, and creating new opportunities to improve patients’ access to trusted medicines across the region and beyond.

H1 2026 revenue reached €850 million – up more than 40% versus H1 2025 Demand continues to grow as more consumers seek better nutrition, health and performance solutions Company growth is broad-based, reflecting successful execution of strategies across brands, product categories, channels, and markets

New study analyzes EV purchase prices and market trends in Germany, Europe's largest car market

Aachen, Germany, 16 July 2026 – Grünenthal announced today that the company has joined the Cluster for Nucleic Acid Therapeutics Munich (CNATM), a Munich-centred innovation network that brings together leading universities, research institutions, biotech companies and industry partners to accelerate next-generation nucleic acid therapeutics into innovative treatments that can make a meaningful difference for patients. Joining the CNATM provides Grünenthal with a valuable platform to strengthen its oligonucleotide drug discovery capabilities and connect its growing internal expertise with one of Germany’s leading academic and biotech innovation ecosystems. Over the last few years, Grünenthal has built strategic in-house capabilities to advance oligonucleotide modalities, including antisense oligonucleotides (ASOs) and small interfering RNA (siRNA), as potential therapeutic approaches for pain and related neurological indications. One of Grünenthal’s key objectives for the collaboration

Three prize tiers, one big goal: from 15 July 2026, the digital energy supplier specialising in renewable energy is giving away instant prizes, monthly non-cash prizes and a top prize of €1,000,000. The full terms and conditions of participation set out all the details.

Better safe than sorry: the emporiaSMART.8 with Smartcover and rubber protectors

Aachen – FEV is collaborating with Microsoft to integrate powerful, in-vehicle Generative AI capabilities . The cooperation aims to enable multimodal voice, text, and gesture interactions directly in the vehicle – independent of a permanent Internet connection.

SAN JOSE, Kalifornien – 08 juli 2026 – Adobe utökar tillgängligheten till Acrobat Studio och Acrobat AI Assistant i Sverige. De AI-drivna funktionerna för produktivitet och kreativitet erbjuds nu även på svenska, så att användarna kan använda dem på sitt lokala språk. Acrobat Studio kombinerar Adobe Acrobat Pro, Adobe Express Premium och intelligenta AI-assistenter. Acrobat AI Wizard erbjuds dessutom som ett separat tillägg för alla Adobe Acrobat-produkter (Acrobat Reader, Acrobat Standard och Acrobat Pro) – ett flexibelt alternativ för alla som vill använda AI-drivna funktioner endast när de arbetar med dokument. Båda dessa erbjudanden gör det möjligt för användare att snabbare komma åt information i PDF-filer och Office-dokument, skapa innehåll och effektivisera arbetsflöden. Acrobat Studio och Acrobat AI Assistant är en viktig milstolpe i vidareutvecklingen av PDF, som har etablerat sig över hela världen som standardformatet för viktiga dokument sedan Adobes lansering år 1993. Acrob

Aachen, 08 July 2026 – Grünenthal announced today that its investigational compound tegacorat (GRM-01) received Orphan Drug and Rare Pediatric Disease Designations from the US Food and Drug Administration (FDA) for the treatment of Duchenne muscular dystrophy (DMD). Tegacorat, a non-steroidal Selective Glucocorticoid Receptor Agonist and Modulator (SEGRAM), is an orally available investigational compound being developed to provide an alternative to glucocorticoid-based treatments such as prednisone, the current standard of care in DMD. Conventional glucocorticoids bind to the glucocorticoid receptor and influence gene expression. Among other mechanisms, this triggers two patterns of activity: transrepression, mainly linked to anti-inflammatory effects, and transactivation, predominantly associated with metabolic and growth-related side effects. In contrast, SEGRAMs are designed to influence receptor activity in a way that emphasises anti-inflammatory pathways. While this has not yet be

The investigational compound has a unique mechanism of action and the potential to become a first-in-class therapy option for the treatment of acute and chronic pain. In a Phase I trial, the investigational compound was demonstrated to be safe and well tolerated. A Phase II trial will commence later this year.

European routers enjoy a high level of trust across Europe (60%) For half of Europeans (55%), the ‘Made in Europe’ label important to when making a purchase More than half of consumers in Sweden mistrust routers from Chinese manufacturers (60%) Many mistrust devices made in the USA

Berlin, 24 June 2026 – The Sovereignty Alliance for European Network Technology (SAFENet), together with the Innovate Europe Foundation (IE.F) and Berlin-based consultancy iconomy, publishes a new foundational study revealing that 93% of European internet traffic flows through routers and yet the EU has no sovereignty framework for this key component of the digital ecosystem. Meanwhile, Chinese manufacturers already control 37% of the market.

Hamburg/Trieste, 21 Jun 2026. The big moment had arrived: to the applause of thousands of guests on board, the champagne bottle was smashed against the bow of Mein Schiff Flow. Accompanied by a spectacular show and an elaborately staged ceremony, the second ship in the InTUItion class was officially welcomed into the Mein Schiff fleet. The naming ceremony marked a first in several respects: for the first time in the history of TUI Cruises, three women – Julia, Annabelle and Karin – jointly acted as godmothers to the new ship. Together, they represent the diversity of the guests and the many personal stories that connect people with the Mein Schiff fleet. For their grand entrance, the three godmothers wore couture dresses selected by designer Guido Maria Kretschmer. A naming ceremony day to celebrate the motto “Go with the Flow” From the afternoon onwards, Mein Schiff Flow was entirely in keeping with the motto of its naming ceremony, “Go with the Flow”. The ship was transformed into an